NUVATION BIO INC.
Last · NYSE$4.68-0.04 (-0.85%)close · yahoo · 9h ago
Vol 3.78M ≈ 17.69M
MA10MA20MA50
Market cap$1.64B350.1M sh
P/E · TTM-10.6fwd -312 · eps -0.44 · loss
Beta1.62vs S&P 500
Div yield0.00%annual · TTM
52w range
$3.36$9.75
Volume3.8Msession
Issuer
Legal nameNUVATION BIO INC.
HQUnited States (US)
ListingUS NUVB
ISINUS67080N1019
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001811063
CIK0001811063
Websitewww.nuvationbio.com
Employees307
AddressNuvation Bio, Inc. 1500 Broadway 10036, New York
| Revenue | $114.9M |
|---|---|
| Operating income | $-47.2M |
| Net income | $-57.4M |
| Operating margin | -41.0% |
| Net margin | -50.0% |
| Return on equity | -22.6% |
| Period | 2026 |
Loading chart…
Upcoming earnings
MON.2NOV
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.09
Est. revenue
34.8M
Earnings transcripts
Documents
FormReporting forFiledFlags
Showing 5 of 26 filings